Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127872711 | 12787271 | 1 | I | 2011 | 20160923 | 20160928 | 20160928 | EXP | GXKR2016DE004510 | SANDOZ | 0.00 | Y | 0.00000 | 20160928 | OT | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127872711 | 12787271 | 1 | PS | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 20 MG, ONCE DAILY | Y | 76397 | 20 | MG | QD | ||||||
127872711 | 12787271 | 2 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, UNK | Y | Y | 0 | 40 | MG | ||||||
127872711 | 12787271 | 3 | SS | INEGY | EZETIMIBESIMVASTATIN | 1 | Oral | 1 DF, ONCE DAILY | 1827 | DF | Y | 0 | 1 | DF | QD | ||||
127872711 | 12787271 | 4 | SS | SORTIS | ATORVASTATIN | 1 | Oral | 20 MG, ONCE DAILY | Y | Y | 0 | 20 | MG | QD | |||||
127872711 | 12787271 | 5 | SS | SORTIS | ATORVASTATIN | 1 | Oral | 20 MG, ONCE DAILY | Y | Y | 0 | 20 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127872711 | 12787271 | 1 | Product used for unknown indication |
127872711 | 12787271 | 2 | Product used for unknown indication |
127872711 | 12787271 | 3 | Product used for unknown indication |
127872711 | 12787271 | 4 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127872711 | 12787271 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127872711 | 12787271 | Blood creatine phosphokinase increased | |
127872711 | 12787271 | Hypoaesthesia | |
127872711 | 12787271 | Myalgia | |
127872711 | 12787271 | Polyneuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127872711 | 12787271 | 1 | 20110728 | 20111110 | 0 | |
127872711 | 12787271 | 2 | 2005 | 0 | ||
127872711 | 12787271 | 3 | 2006 | 2011 | 0 | |
127872711 | 12787271 | 4 | 1999 | 0 | ||
127872711 | 12787271 | 5 | 2004 | 0 |